AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30713722 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 10 mg twice daily
Number of subjects: 394
Study 30713722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 394
Study 29203893 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Loss (WL) intervention (1200-1500 Kcal/day meal plans and physical activity)
Number of subjects: 44
Study 29203893 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Loss (WL) intervention
Number of subjects: 44
Study 29203893 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 44
Study 27480315 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood flow restriction (70% arterial occlusion) during low-load resistance training
Number of subjects: 13
Study 27480315 — intervention group
Group type: COMPARATOR
Intervention: Control group (one set of elbow flexion at 70% 1RM to volitional fatigue)
Number of subjects: 13
Study 24067745 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice (200 ml, three times daily for 3 days)
Number of subjects: 14
Study 24067745 — intervention group
Group type: COMPARATOR
Intervention: Water (control)
Number of subjects: 14
Study 23469595 — intervention group
Group type: EXPERIMENTAL
Intervention: Shuangshen Tongguan Capsule (STC), 4 pills each time, three times daily
Number of subjects: 129
Study 23469595 — intervention group
Group type: COMPARATOR
Intervention: STC Placebo
Number of subjects: 129
Study 20038536 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin A supplementation
Number of subjects: 127
Study 17698615 — intervention group
Group type: EXPERIMENTAL
Intervention: Pramlintide (60 or 120 microg b.i.d./t.i.d.)
Number of subjects: 212
Study 17698615 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 212
Study 17698615 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 212
Study 15764047 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluocinolone acetonide 0.01% in oil
Number of subjects: 0
Study 15764047 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control)
Number of subjects: 0
Study 11838013 — intervention group
Group type: EXPERIMENTAL
Intervention: Medline searches using MeSH-terms for endodontics
Number of subjects: 0
Study 11838013 — intervention group
Group type: EXPERIMENTAL
Intervention: Medline searches using MeSH-terms for orthodontics
Number of subjects: 0
Study 11838013 — intervention group
Group type: EXPERIMENTAL
Intervention: Medline searches using MeSH-terms for pediatric dentistry
Number of subjects: 0
Study 11838013 — intervention group
Group type: EXPERIMENTAL
Intervention: Medline searches using MeSH-terms for public health dentistry
Number of subjects: 0
Study 9725399 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose aprotinin
Number of subjects: 45
Study 9725399 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose aprotinin
Number of subjects: 45
Study 9725399 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 7530944 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 5 mg/day
Number of subjects: 1600
Study 7530944 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride 1 mg/day
Number of subjects: 1600
Study 7530944 — intervention group
Group type: EXPERIMENTAL
Intervention: Finasteride (both dosages)
Number of subjects: 1600
Study 7530944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1600
Study 2536516 — intervention group
Group type: EXPERIMENTAL
Intervention: Prazosin
Number of subjects: 15
Study 2536516 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 15
Study 30944162 — intervention group
Group type: EXPERIMENTAL
Intervention: 7 days of peroral metronidazole/amoxicillin antibiotic treatment
Number of subjects: 0
Study 30944162 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic treatment (control group)
Number of subjects: 0
Study 27055804 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 minutes of motor imagery with music, six times per week for 4 weeks
Number of subjects: 112
Study 27055804 — intervention group
Group type: EXPERIMENTAL
Intervention: 17 minutes of motor imagery with metronome cues, six times per week for 4 weeks
Number of subjects: 112
Study 27055804 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 112
Study 25485893 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise (8 exercises, 2 sets of 10 repetitions at an intensity of 5‐7 in the OMNI Resistance Exercise Scale)
Number of subjects: 14
Study 25485893 — intervention group
Group type: COMPARATOR
Intervention: Control (rest for 30 min)
Number of subjects: 14
Study 23787722 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous ferric carboxymaltose (FCM)
Number of subjects: 459
Study 23787722 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 459
Study 22099238 — intervention group
Group type: EXPERIMENTAL
Intervention: AchieveTogether (12-week web-based intervention)
Number of subjects: 100
Study 22099238 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 100
Study 19440788 — intervention group
Group type: EXPERIMENTAL
Intervention: Kugel repair
Number of subjects: 40
Study 19440788 — intervention group
Group type: COMPARATOR
Intervention: TEP repair
Number of subjects: 40
Study 15641975 — intervention group
Group type: EXPERIMENTAL
Intervention: AH plus
Number of subjects: 55
Study 15641975 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoRez
Number of subjects: 55
Study 15641975 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 55
Study 10589608 — intervention group
Group type: EXPERIMENTAL
Intervention: NO delivered into the MO (100 ppm)
Number of subjects: 47
Study 10589608 — intervention group
Group type: COMPARATOR
Intervention: Control group (CPB without NO)
Number of subjects: 47
Study 8756815 — intervention group
Group type: EXPERIMENTAL
Intervention: rhDNase 2.5 mg twice daily
Number of subjects: 0
Study 8756815 — intervention group
Group type: EXPERIMENTAL
Intervention: rhDNase once daily
Number of subjects: 0
Study 8756815 — intervention group
Group type: COMPARATOR
Intervention: Placebo (excipient only) inhalation
Number of subjects: 0
Study 2017519 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluoxetine treatment (chronic)
Number of subjects: 6
Study 2017519 — intervention group
Group type: COMPARATOR
Intervention: mCPP (0.5 mg/kg)
Number of subjects: 6
Study 6210751 — intervention group
Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 50
Study 6210751 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 31005993 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg
Number of subjects: 482
Study 31068182 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet count quintile grouping (Q1, Q3, Q5)
Number of subjects: 1797
Study 31068182 — intervention group
Group type: COMPARATOR
Intervention: Normal platelet counts (≥150 to <300 × 10^9/L)
Number of subjects: 1797
Study 31068182 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet count
Number of subjects: 1797
Study 29554191 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported stuttering severity ratings (SRs)
Number of subjects: 3
Study 29554191 — intervention group
Group type: EXPERIMENTAL
Intervention: Percentage of syllables stuttered (%SS)
Number of subjects: 3
Study 27857631 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive soft tissue therapy
Number of subjects: 42
Study 27857631 — intervention group
Group type: EXPERIMENTAL
Intervention: Active soft tissue therapy
Number of subjects: 42
Study 27857631 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure (Control group)
Number of subjects: 42
Study 24317552 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 % elbow extensor activation
Number of subjects: 11
Study 24317552 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 % elbow flexor activation
Number of subjects: 11
Study 20965712 — intervention group
Group type: EXPERIMENTAL
Intervention: Beclomethasone/formoterol (200/12 μg)
Number of subjects: 703
Study 20965712 — intervention group
Group type: COMPARATOR
Intervention: Budesonide/formoterol (400/12 μg)
Number of subjects: 703
Study 20965712 — intervention group
Group type: COMPARATOR
Intervention: Formoterol (12 μg)
Number of subjects: 703
Study 17346628 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab
Number of subjects: 35
Study 17346628 — intervention group
Group type: COMPARATOR
Intervention: RATG
Number of subjects: 35
Study 15319308 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple monetary gambling tasks with no active choices (experiment 1)
Number of subjects: 0
Study 15319308 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple monetary gambling tasks with no overt actions (experiment 2)
Number of subjects: 0
Study 15319308 — intervention group
Group type: COMPARATOR
Intervention: Gambling task with outcomes contingent upon participants' response choices
Number of subjects: 0
Study 12079598 — intervention group
Group type: EXPERIMENTAL
Intervention: Real auricular acupuncture intervention
Number of subjects: 30
Study 12079598 — intervention group
Group type: COMPARATOR
Intervention: Sham or placebo auricular acupuncture
Number of subjects: 30
Study 12079598 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined experimental and control groups
Number of subjects: 30
Study 9559810 — intervention group
Group type: EXPERIMENTAL
Intervention: Grapefruit juice
Number of subjects: 12
Study 9559810 — intervention group
Group type: COMPARATOR
Intervention: Water
Number of subjects: 12
Study 8536392 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiographic characteristics of patients who suffered a stroke (n = 50)
Number of subjects: 150
Study 8536392 — intervention group
Group type: COMPARATOR
Intervention: Angiograms of 50 patients who suffered a stroke
Number of subjects: 150
Study 2238169 — intervention group
Group type: EXPERIMENTAL
Intervention: rHu‐EPO
Number of subjects: 19
Study 2238169 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 29369660 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer mentoring intervention
Number of subjects: 22
Study 28469157 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone 10 mg/kg BID
Number of subjects: 22
Study 28469157 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone 15 mg/kg BID
Number of subjects: 22
Study 28469157 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 28469157 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone 30 mg/kg
Number of subjects: 22
Study 28469157 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferiprone
Number of subjects: 22
Study 25895855 — intervention group
Group type: EXPERIMENTAL
Intervention: Religious coping
Number of subjects: 436
Study 25153911 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose restricted diet (group A)
Number of subjects: 103
Study 25153911 — intervention group
Group type: COMPARATOR
Intervention: No diet (group B)
Number of subjects: 103
Study 21601396 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehydration using a carbohydrate‐electrolyte beverage (CE)
Number of subjects: 14
Study 21601396 — intervention group
Group type: COMPARATOR
Intervention: Control conditions (Cont) with no prehydration
Number of subjects: 14
Study 21601396 — intervention group
Group type: EXPERIMENTAL
Intervention: Prehydration using water (W)
Number of subjects: 14
Study 19804430 — intervention group
Group type: EXPERIMENTAL
Intervention: Temsirolimus
Number of subjects: 0
Study 19804430 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alpha
Number of subjects: 0
Study 17426326 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental approach for weight gain prevention
Number of subjects: 670
Study 17426326 — intervention group
Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 670
Study 16354214 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium cromoglycate (SCG)
Number of subjects: 82
Study 16354214 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide (BUD)
Number of subjects: 82
Study 16354214 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 82
Study 12037450 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcipotriol ointment/scalp solution (80-100 g/week and 30-50 ml/week, respectively)
Number of subjects: 88
Study 12037450 — intervention group
Group type: COMPARATOR
Intervention: Dithranol/tar regimen
Number of subjects: 88
Study 10574363 — intervention group
Group type: EXPERIMENTAL
Intervention: Pursuit maintenance
Number of subjects: 0
Study 10574363 — intervention group
Group type: EXPERIMENTAL
Intervention: Stimuli flashed ahead of the pursuit target
Number of subjects: 0
Study 8535669 — intervention group
Group type: EXPERIMENTAL
Intervention: Ileal conduit
Number of subjects: 56
Study 8535669 — intervention group
Group type: EXPERIMENTAL
Intervention: Colonic conduit
Number of subjects: 56
Study 8535669 — intervention group
Group type: EXPERIMENTAL
Intervention: Continent caecal reservoir
Number of subjects: 56
Study 8535669 — intervention group
Group type: COMPARATOR
Intervention: Conduit diversion (both ileal and colonic)
Number of subjects: 56
Study 8535669 — intervention group
Group type: EXPERIMENTAL
Intervention: Ureteric reimplantation
Number of subjects: 56
Study 8535669 — intervention group
Group type: EXPERIMENTAL
Intervention: Balloon dilatation
Number of subjects: 56
Study 8535669 — intervention group
Group type: EXPERIMENTAL
Intervention: Uretero-intestinal anastomoses
Number of subjects: 56
Study 2230067 — intervention group
Group type: EXPERIMENTAL
Intervention: Adinazolam
Number of subjects: 30
Study 2230067 — intervention group
Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 30
Study 139852 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole (400 mg three times daily for 10-20 days)
Number of subjects: 229
Study 139852 — intervention group
Group type: EXPERIMENTAL
Intervention: Metronidazole
Number of subjects: 229
Study 139852 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 229
Study 31558370 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT)
Number of subjects: 40
Study 31558370 — intervention group
Group type: COMPARATOR
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 40
Study 31276710 — intervention group
Group type: COMPARATOR
Intervention: Emotional messaging intervention
Number of subjects: 180
Study 31276710 — intervention group
Group type: COMPARATOR
Intervention: Informational messaging intervention
Number of subjects: 180
Study 31276710 — intervention group
Group type: COMPARATOR
Intervention: Control condition (messages on sugar consumption)
Number of subjects: 180
Study 28067982 — intervention group
Group type: EXPERIMENTAL
Intervention: GAN group (posterior branch preserved)
Number of subjects: 130
Study 28067982 — intervention group
Group type: COMPARATOR
Intervention: non-GAN group (posterior branch ligated)
Number of subjects: 130
Study 25867865 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise training (RET) for 20 weeks
Number of subjects: 20
Study 25867865 — intervention group
Group type: COMPARATOR
Intervention: Control group (untrained men)
Number of subjects: 20
Study 23453095 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced shielding with a 0.5‐mm lead apron across the patient's abdomen
Number of subjects: 0
Study 23453095 — intervention group
Group type: COMPARATOR
Intervention: Standard shielding
Number of subjects: 0
Study 21597217 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-irradiated intensity of 600 mW/cm(2) with translucent shade resin
Number of subjects: 0
Study 21597217 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-irradiated intensity of 350 mW/cm(2) with translucent shade resin using SE and BF
Number of subjects: 0
Study 21597217 — intervention group
Group type: EXPERIMENTAL
Intervention: Light-irradiated intensity of 350 mW/cm(2) with TS
Number of subjects: 0
Study 21597217 — intervention group
Group type: COMPARATOR
Intervention: Light-irradiated intensity of 600 mW/cm(2) with opaque shade resin
Number of subjects: 0
Study 21597217 — intervention group
Group type: COMPARATOR
Intervention: Light-irradiated intensity of 350 mW/cm(2) with opaque shade resin
Number of subjects: 0
Study 19548028 — intervention group
Group type: EXPERIMENTAL
Intervention: Double Tract (DT) reconstruction
Number of subjects: 44
Study 19548028 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y (R-Y) reconstruction
Number of subjects: 44
Study 17584567 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiazolidinedione therapy (pioglitazone or rosiglitazone)
Number of subjects: 235
Study 15089940 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium hydroxide suspension [Ca(OH)2]
Number of subjects: 36
Study 15089940 — intervention group
Group type: EXPERIMENTAL
Intervention: Glutaraldehyde based dentine primer (GDP)
Number of subjects: 36
Study 11294429 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-steroidal anti-inflammatory drugs post-operatively for 3-6 weeks
Number of subjects: 0
Study 11294429 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy
Number of subjects: 0
Study 11294429 — intervention group
Group type: EXPERIMENTAL
Intervention: Simple analgesia in the first 1-2 days following surgery and a well-planned home-based exercise program
Number of subjects: 0
Study 9257419 — intervention group
Group type: EXPERIMENTAL
Intervention: Spreadsheet method for displaying drug dosing histories
Number of subjects: 0
Study 8177603 — intervention group
Group type: EXPERIMENTAL
Intervention: Infrared coagulation
Number of subjects: 1537
Study 8177603 — intervention group
Group type: COMPARATOR
Intervention: Rubber band ligation
Number of subjects: 1537
Study 8177603 — intervention group
Group type: COMPARATOR
Intervention: Sclero cryo therapy
Number of subjects: 1537
Study 3308389 — intervention group
Group type: EXPERIMENTAL
Intervention: L-5-HTP
Number of subjects: 48
Study 3308389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 29320587 — intervention group
Group type: COMPARATOR
Intervention: Basic skin care regimen following hyaluronic acid filler and neurotoxin treatment
Number of subjects: 20
Study 29320587 — intervention group
Group type: EXPERIMENTAL
Intervention: Nu‐Derm® skin care system (Obagi Medical Products, Inc) following treatment
Number of subjects: 20
Study 27097354 — intervention group
Group type: EXPERIMENTAL
Intervention: Albumin
Number of subjects: 200
Study 27097354 — intervention group
Group type: EXPERIMENTAL
Intervention: Terlipressin
Number of subjects: 200
Study 27097354 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose albumin plus terlipressin
Number of subjects: 200
Study 27097354 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 200
Study 27097354 — intervention group
Group type: COMPARATOR
Intervention: Albumin (control group)
Number of subjects: 200
Study 26226481 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine
Number of subjects: 22
Study 26226481 — intervention group
Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 22
Study 26226481 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 22
Study 24152576 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil application
Number of subjects: 0
Study 24152576 — intervention group
Group type: COMPARATOR
Intervention: HOFA application
Number of subjects: 0
Study 21309374 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensory Integration (SI) treatment group
Number of subjects: 0
Study 21309374 — intervention group
Group type: COMPARATOR
Intervention: Fine motor treatment group
Number of subjects: 0
Study 17951278 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous salbutamol
Number of subjects: 0
Study 17951278 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung lavage fluid from patients treated with salbutamol
Number of subjects: 0
Study 17951278 — intervention group
Group type: EXPERIMENTAL
Intervention: In vitro salbutamol
Number of subjects: 0
Study 17027730 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral misoprostol
Number of subjects: 1620
Study 17027730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1620
Study 15080821 — intervention group
Group type: EXPERIMENTAL
Intervention: Desloratadine (DES) 5 mg
Number of subjects: 16
Study 15080821 — intervention group
Group type: EXPERIMENTAL
Intervention: Fexofenadine (FEX) 180 mg
Number of subjects: 16
Study 15080821 — intervention group
Group type: EXPERIMENTAL
Intervention: Levocetirizine (LEV) 5 mg
Number of subjects: 16
Study 15080821 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 16
Study 11280457 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg azithromycin once a day for four days per month along with 0.05% topical tretinoin for a total of 12 weeks
Number of subjects: 60
Study 11280457 — intervention group
Group type: COMPARATOR
Intervention: 100 mg doxycycline daily in addition to topical 0.05% tretinoin cream for a total of 12 weeks
Number of subjects: 60
Study 9249114 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 16
Study 9249114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8504628 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous low dose aspirin (50 mg)
Number of subjects: 10
Study 8504628 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous high dose aspirin (500 mg)
Number of subjects: 10
Study 8504628 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 3323256 — intervention group
Group type: EXPERIMENTAL
Intervention: A-49816 (0.5 to 20 mg)
Number of subjects: 18
Study 3323256 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 31703936 — intervention group
Group type: EXPERIMENTAL
Intervention: Full dose (n=14)
Number of subjects: 44
Study 31703936 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/5th dose (n=17)
Number of subjects: 44
Study 31703936 — intervention group
Group type: EXPERIMENTAL
Intervention: 1/25th dose (n=13)
Number of subjects: 44
Study 30549483 — intervention group
Group type: EXPERIMENTAL
Intervention: News article featuring an interview with a suicide expert disclosing personal experience of suicidal ideation
Number of subjects: 545
Study 30549483 — intervention group
Group type: EXPERIMENTAL
Intervention: News article featuring an interview with a suicide expert without disclosure of personal experience
Number of subjects: 545
Study 30549483 — intervention group
Group type: COMPARATOR
Intervention: Article unrelated to suicide
Number of subjects: 545